Alzheimer’s Disease: Description and Primary Source Analysis

Summary

Alzheimer’s disease has been notoriously known for producing devastating effects on the lives of elderly people. According to the local epidemiological data on Alzheimer’s disease, around 130,000 Georgian citizens suffer from the disorder (Georgia Department of Public Health, 2020). Given the severe consequences of Alzheimer’s, particularly, the rapid deterioration of cognitive functions, further research into the subject matter is urgently needed. In their article, Huang et al. (2020) study the effects that the 630-nm Red Light as one of the possible intervention tools has on the development of Alzheimer’s disease in aging people.

Purpose

The goal of the primary research conducted by Huang et al. (2020) is to examine the opportunities that the use of 630-nm Red Light offers for patients with Alzheimer’s. Namely, the authors study the changes in patients’ memory and the extent in its improvement after being exposed to the 630-nm Red Light-based therapy.

Discussion

The article under analysis has multiple strengths, one of which concerns its specific focus. Namely, the authors utilize the randomized controlled trial (RCT) framework to study the effects of the 630-nm Red Light treatment concept on the well-being of patients. Due to the use of RCT, the outcomes of the analysis are especially accurate. The article confirms that the adoption of the 630-nm Red Light framework helps to improve memory-related skills in aging patients with Alzheimer’s disease. However, further introspect into the subject matter, as well as more detailed tests for different types of populations, will be required to establish the 630-nm Red Light approach as the cornerstone practice for addressing Alzheimer’s.

Importance

The research by Huang et al. (2020) has tremendous importance for patients with Alzheimer’s since it seeks to analyze the available treatment opportunities that have not been introduced to the health care setting yet. Thus, the efficacy of the proposed treatment tools can be evaluated to implement innovative treatment opportunities in the contemporary healthcare setting and improve the quality of life in people suffering from Alzheimer’s disease.

References

Georgia Department of Public Health. (2020). Alzheimer’s disease. Web.

Huang, N., Yao, D., Jiang, W., Wei, C., Li, M., Li, W., Mu, H., Gao, M., Ma, Z., Lyu, J., & Tong, Z. (2020). Safety and efficacy of 630-nm Red Light on cognitive function in older adults with mild to moderate Alzheimer’s disease: Protocol for a randomized controlled study. Frontiers in Aging Neuroscience, 12(143), 1-9. Web.